Nalaganje...
Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes
BACKGROUND: Exenatide once weekly, an injectable glucagon-like peptide-1 receptor agonist, has been shown to reduce A1C, fasting glucose, and body weight in patients with type 2 diabetes. Exenatide 2.0 mg is dispersed in poly-(D,L-lactide-co-glycolide) polymer microspheres, which require resuspensio...
Shranjeno v:
| izdano v: | J Diabetes Sci Technol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4525643/ https://ncbi.nlm.nih.gov/pubmed/25759181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296815576186 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|